Form 4: Director Julie Larson-Green Receives HCAT Stock Grant

Health Catalyst, Inc. director Julie Larson-Green was granted 12,710 restricted stock units that vested immediately on June 1, 2026.

Summary

• Director Julie Larson-Green acquired 12,710 shares of Health Catalyst, Inc. (HCAT) common stock.
• The acquisition was in the form of restricted stock units (RSUs) granted under the 2019 Stock Option and Incentive Plan.
• The shares were granted at a price of $0.00 per share.
• The RSUs vested 100% on June 1, 2026, in accordance with the company's Non-Employee Director Compensation Policy.
• Following this transaction, the director's total beneficial ownership is 94,644 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial strategy.

Positives

• Director alignment with shareholder interests is reinforced through increased equity ownership.
• The grant follows standard non-employee director compensation policies.

Negatives

• None identified.

Risks

• Equity-based compensation is subject to market volatility affecting the value of director holdings.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard practice in the healthcare technology sector to ensure board members maintain a vested interest in long-term corporate performance.

Comparison to Industry Standards

• The use of RSUs for director compensation is consistent with standard corporate governance practices for mid-cap technology firms.
• Immediate vesting upon grant is a common feature for annual director equity retainers in the U.S. market.

Stakeholder Impact

• Minor dilution impact, though standard for director compensation programs.

Next Steps

• None mentioned.

Key Dates

Keywords

HCAT, Health Catalyst, Form 4, Insider Transaction, Director Compensation, Restricted Stock Units